Clinical trials
Phase 1/2 Colorectal Neoplasms trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 3 |
| Cantargia AB | 1 |
| GlaxoSmithKline | 1 |
| Isofol Medical AB | 1 |
| Oncoinvent Solutions AS | 1 |
| St. Olavs Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 8 |
| Gastrointestinal Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Gastrointestinal Diseases | 1 |
| Intestinal Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Peritoneal Neoplasms | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.